Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Proliferative Breast Disease”

38 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 38 results

Very early researchStudy completedNCT03954015
What this trial is testing

Comparison of Three Methods for Early Detection of Breast Cancer

Who this might be right for
Proliferative Breast Disease
Mayo Clinic 3
Testing effectiveness (Phase 2)Study completedNCT00930579
What this trial is testing

Pre-Surgical Study: Effect of Metformin on Breast Cancer Proliferation

Who this might be right for
Breast Cancer
Columbia University 35
Not applicableActive Not RecruitingNCT03657628
What this trial is testing

Physical Activity, Proliferation and Immune Markers in Benign Breast Tissue

Who this might be right for
Breast Cancer
Dana-Farber Cancer Institute 60
Testing effectiveness (Phase 2)WithdrawnNCT01814865
What this trial is testing

Anti-Proliferative Effects and Genomic Alterations of Abiraterone Acetate Compared to an Aromatase Inhibitor in Post-menopausal HR+ Operable Breast Cancer

Who this might be right for
Post-menopausal ER+ Stage I-IIIA Primary Operable Breast Cancer
British Columbia Cancer Agency
Testing effectiveness (Phase 2)WithdrawnNCT00252811
What this trial is testing

ZD1839 Effects on Cell Proliferation in Breast Cancer

Who this might be right for
Breast Cancer
AstraZeneca 60
Testing effectiveness (Phase 2)Study completedNCT01015131
What this trial is testing

18F-FLT-PET in Breast Cancer (MK-0000-139)

Who this might be right for
Breast Cancer
Merck Sharp & Dohme LLC 46
Not applicableStudy completedNCT01016665
What this trial is testing

Anastrozole Reduced Proliferation and Progesterone Receptor Indexes in Short Term Hormone Therapy

Who this might be right for
Breast Cancer
Federal University of São Paulo 71
Not applicableStudy completedNCT06309459
What this trial is testing

Carbonic Anhydrase IX Enzyme in Triple Negative Breast Carcinoma

Who this might be right for
Triple Negative Breast CancerCarbonic Anhydrase IX
Kahramanmaras Sutcu Imam University 40
Early research (Phase 1)Ended earlyNCT02936206
What this trial is testing

Examination of Breast Cancer Cells of Pre-menopausal and Post-menopausal Women Before and After Exposure to Tamoxifen or Fulvestrant.

Who this might be right for
Breast Cancer
Icahn School of Medicine at Mount Sinai 2
Very early researchStudy completedNCT03197389
What this trial is testing

Effect of Pembrolizumab (Keytruda®) on Biomarkers in Early Breast Cancer.

Who this might be right for
Breast CancerTriple Negative Breast CancerHormone Receptor Negative Neoplasm
Universitaire Ziekenhuizen KU Leuven 54
Testing effectiveness (Phase 2)Ended earlyNCT01934335
What this trial is testing

Effect of Vandetanib on Cellular Markers in Invasive Breast Cancer

Who this might be right for
Invasive Breast Cancer
Ronald Weigel 12
Not applicableStudy completedNCT00612560
What this trial is testing

Flaxseed, Aromatase Inhibitors and Breast Tumor Characteristics

Who this might be right for
Breast Cancer
Roswell Park Cancer Institute 28
Testing effectiveness (Phase 2)Study completedNCT01500577
What this trial is testing

A Prevention Trial in Subjects at High Risk for Breast Cancer

Who this might be right for
Breast Cancer
European Institute of Oncology 150
Testing effectiveness (Phase 2)Looking for participantsNCT05728268
What this trial is testing

Neoadjuvant Dose-dense Chemotherapy for HR+/HER2- Breast Cancer Patients With High Proliferation Index

Who this might be right for
Breast Cancer
Shantou Central Hospital 64
Not applicableUnknownNCT00926315
What this trial is testing

Gene Expression Profile of Breast Cancer Samples After Vitamin D Supplementation

Who this might be right for
Breast NeoplasmsPostmenopausal Disorder
University of Sao Paulo General Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00016549
What this trial is testing

Bevacizumab to Treat Inflammatory Breast Cancer or Locally Advanced Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Institute (NCI) 21
Not applicableStudy completedNCT03886389
What this trial is testing

Breast Cancer Diet Intervention Study

Who this might be right for
Early-stage Breast CancerCarbohydrate EngorgementProliferation+2 more
Helse Stavanger HF 80
Testing effectiveness (Phase 2)Study completedNCT01367288
What this trial is testing

Comparative Study of Neoadjuvant Chemotherapy With and Without Zometa for Management of Locally Advanced Breast Cancers

Who this might be right for
Locally Advanced Breast CancerDuctal Histologic TypeWithout Her 2 Overexpression
Hospices Civils de Lyon 53
Early research (Phase 1)Study completedNCT02922127
What this trial is testing

Compare Daily Ulipristal Acetate and Combined Oral Contraceptive Effects on Breast Epithelial Cell Proliferation

Who this might be right for
Contraception
Columbia University 29
Testing effectiveness (Phase 2)Study completedNCT03454529
What this trial is testing

The Effect of Simvastatin on Breast Cancer Cell Growth in Women With Stage I-II Breast Cancer

Who this might be right for
Invasive Breast CarcinomaStage I Breast Cancer AJCC v7Stage IA Breast Cancer AJCC v7+4 more
Michael Simon 24
Load More Results